Shuofeng Li
4PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Feb 10, 2026
Efficacy and safety of pembrolizumab, lenvatinib, and reduced-dose gemcitabine/oxaliplatin as initial treatment for advanced biliary tract cancer: a multicenter, single-arm, prospective, phase II study.Mingjian Piao, Chengjie Li, Shuofeng Li
|Jun 23, 2025
Attenuated immune surveillance during squamous cell transformation of pancreatic adenosquamous cancer defines new therapeutic opportunity for cancer interception.Xinyuan Chen, Shanyue Sun, Shuofeng Li
|Mar 23, 2023
Differences in clinical characteristics and prognosis between breast neuroendocrine carcinoma and breast invasive ductal carcinoma: A multicentre population-based study from China.Ding-Yuan Wang, Shuo-Feng Li, Song-Lin Gao
|Mar 17, 2022
Diabetes and Colorectal Cancer Risk: Clinical and Therapeutic Implications.Guan-Hua Yu, Shuo-Feng Li, Ran Wei
Pageof 1
Frequent Collaborators
1 joint publications
Guan-Hua Yu
1 joint publications
Ran Wei
1 joint publications
Zheng Jiang
1 joint publications
Ding-Yuan Wang
1 joint publications
Song-Lin Gao
1 joint publications
Peng Yuan
1 joint publications
Bai-Lin Zhang
1 joint publications
Xinyuan Chen
1 joint publications
Jie Chen
1 joint publications
Haitao Zhao
